指南与共识临床试验与 GCP流行病学与生物统计

重症患者胃肠道出血预防:临床实践指南

Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.
指南 / 共识 · BMJ · 2020-01-06

该指南由多学科专家组采用GRADE方法制定,基于一项纳入12 660例重症患者、72项试验的系统综述与网络Meta分析。指南弱推荐对临床重要胃肠道出血高风险(>4%)的重症患者使用预防,低风险(≤4%)者不预防;建议首选PPI而非H2RA,反对使用硫糖铝。

要点

  • 高风险(>4%)重症患者弱推荐预防胃肠道出血,低风险(≤4%)弱推荐不预防。
  • 预防药物建议选择PPI而非H2RA(弱推荐),反对使用硫糖铝(强推荐)。
  • PPI与H2RA均降低出血风险但可能增加肺炎风险,对死亡率可能无影响。

核心结论

  • 对临床重要胃肠道出血高风险(>4%)的重症患者弱推荐使用预防,低风险(≤4%)者弱推荐不使用预防。
  • 建议使用PPI而非H2RA(弱推荐),反对使用硫糖铝(强推荐)。

研究设计与样本

  • 指南专家组包括患者、临床医生和方法学家,采用可信指南标准和GRADE方法制定推荐。
  • 推荐基于一项关联的系统综述与网络Meta分析,该分析纳入72项试验、12 660例重症患者。

主要发现

  • PPI和H2RA均降低临床重要出血风险,在高出血风险患者中效应更大(中等确定性)。
  • PPI和H2RA可能增加肺炎风险(低确定性),可能对死亡率、住院时间或其他重要结局无影响(中等确定性)。
  • PPI可能比H2RA更降低出血风险(中等确定性)。

关键数值与推荐

  • 高风险定义为临床重要胃肠道出血风险>4%,低风险定义为≤4%。
  • 高风险因素包括凝血功能障碍、慢性肝病、接受机械通气但未接受肠内营养,或机械通气合并肠内营养、急性肾损伤、脓毒症和休克中两项及以上。

临床怎么用

  • 临床医生应结合患者个体价值观、出血风险及药物可及性等因素,决定是否使用胃肠道出血预防。
  • 对高风险患者可考虑PPI预防,低风险患者可不预防。

局限性

  • 风险因素的确信度不一。
  • 肺炎风险为低确定性证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CLINICAL QUESTION: What is the role of gastrointestinal bleeding prophylaxis (stress ulcer prophylaxis) in critically ill patients? This guideline was prompted by the publication of a new large randomised controlled trial. CURRENT PRACTICE: Gastric acid suppression with proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) is commonly done to prevent gastrointestinal bleeding in critically ill patients. Existing guidelines vary in their recommendations of which population to treat and which agent to use. RECOMMENDATIONS: This guideline panel makes a weak recommendation for using gastrointestinal bleeding prophylaxis in critically ill patients at high risk (>4%) of clinically important gastrointestinal bleeding, and a weak recommendation for not using prophylaxis in patients at lower risk of clinically important bleeding (≤4%). The panel identified risk categories based on evidence, with variable certainty regarding risk factors. The panel suggests using a PPI rather than a H2RA (weak recommendation) and recommends against using sucralfate (strong recommendation). HOW THIS GUIDELINE WAS CREATED: A guideline panel including patients, clinicians, and methodologists produced these recommendations using standards for trustworthy guidelines and the GRADE approach. The recommendations are based on a linked systematic review and network meta-analysis. A weak recommendation means that both options are reasonable. THE EVIDENCE: The linked systematic review and network meta-analysis estimated the benefit and harm of these medications in 12 660 critically ill patients in 72 trials. Both PPIs and H2RAs reduce the risk of clinically important bleeding. The effect is larger in patients at higher bleeding risk (those with a coagulopathy, chronic liver disease, or receiving mechanical ventilation but not enteral nutrition or two or more of mechanical ventilation with enteral nutrition, acute kidney injury, sepsis, and shock) (moderate certainty). PPIs and H2RAs might increase the risk of pneumonia (low certainty). They probably do not have an effect on mortality (moderate certainty), length of hospital stay, or any other important outcomes. PPIs probably reduce the risk of bleeding more than H2RAs (moderate certainty). UNDERSTANDING THE RECOMMENDATION: In most critically ill patients, the reduction in clinically important gastrointestinal bleeding from gastric acid suppressants is closely balanced with the possibility of pneumonia. Clinicians should consider individual patient values, risk of bleeding, and other factors such as medication availability when deciding whether to use gastrointestinal bleeding prophylaxis. Visual overviews provide the relative and absolute benefits and harms of the options in multilayered evidence summaries and decision aids available on MAGICapp.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020. PMID: 31907223. doi:10.1136/bmj.l6722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。